Melatonin Attenuates RANKL-Induced Osteoclastogenesis Via Inhibition of Atp6v0d2 and DC-STAMP Through MAPK and NFATc1 Signaling Pathways
Affiliations
Methods: the cytotoxic effect of melatonin was investigated by MTT assay. Osteoclast differentiation and gene expression of osteoclast-related factors were confirmed via TRAP staining, pit formation assay, immunofluorescence imaging, western blot, and real-time PCR.
Results: melatonin was found to inactivate the p38 and JNK of MAP kinase in RAW264.7 cells treated with RANKL and treated with a combination RANKL and melatonin for 1, 3, and 5 days. The melatonin treatment group showed a reduction in osteoclastogenesis transcription factors and ATP6v0d2 gene expression.
Conclusions: melatonin inhibits osteoclast differentiation and cell fusion by inhibiting the expression of Atp6v0d2 through the inactivation of MAPK and NFATc1 signaling in RANKL-stimulated RAW264.7 macrophages. The findings of the present study suggest that melatonin could be a suitable therapy for bone loss and imply a potential role of melatonin in bone health.
Sun Q, Xu L, Hu Z, Liu J, Yu T, Li M Curr Issues Mol Biol. 2024; 46(9):9624-9638.
PMID: 39329924 PMC: 11430354. DOI: 10.3390/cimb46090572.
Kim J, Song H, Cheon S, An S, Lee C, Kim S Sci Rep. 2023; 13(1):21575.
PMID: 38062113 PMC: 10703878. DOI: 10.1038/s41598-023-49024-1.
Small-molecule amines: a big role in the regulation of bone homeostasis.
Zhang Q, Yang J, Hu N, Liu J, Yu H, Pan H Bone Res. 2023; 11(1):40.
PMID: 37482549 PMC: 10363555. DOI: 10.1038/s41413-023-00262-z.
Beneficial Effects of Melatonin on Periodontitis Management: Far More Than Oral Cavity.
Wang C, Wang L, Wang X, Cao Z Int J Mol Sci. 2022; 23(23).
PMID: 36498871 PMC: 9739298. DOI: 10.3390/ijms232314541.
The role of melatonin in the development of postmenopausal osteoporosis.
Yang K, Qiu X, Cao L, Qiu S Front Pharmacol. 2022; 13:975181.
PMID: 36278157 PMC: 9585202. DOI: 10.3389/fphar.2022.975181.